Long-Term Outcomes
The primary end-point of all-cause mortality at 8 years was not significantly across any of the three treatment groups (HCR 5.0%vs. CABG 4.0% vs . PCI 9.0%) (Figure 2). There was also no significant difference in the incidence of repeat revascularization between the three patient groups (HCR 16.0% vs. CABG 11.0%vs. PCI 18.0%) (Figure 3). Repeat revascularization rates on a previously treated coronary artery (‘target vessel revascularization’) were similarly comparable between patient cohorts (HCR 6.0% vs.CABG 5.0% vs. PCI 10.0%) (Table 4). A composite MACE end-point encompassing death, repeat revascularization and new myocardial infarction did not demonstrate significant difference at 8 years, regardless of the technique of revascularization (Figure 4).